Neko Health Secures $700M to Bring AI-Powered Preventive Scans to the US

Neko Health Secures $700M to Bring AI-Powered Preventive Scans to the US

For readers tracking the shift, Neko Health, the innovative health tech company co-founded by Spotify’s Daniel Ek, has announced a significant Series C funding round of $700 million. This substantial investment is earmarked for an ambitious expansion into the United States, beginning with a flagship clinic in New York. Neko Health aims to redefine preventive healthcare by offering comprehensive, AI-driven body scans designed to identify potential health risks early.

The Funding Powering Expansion

Meanwhile, The Series C round saw strong participation, led by Lightspeed Venture Partners and co-led by O.G. Venture Partners.

Existing investors like Atomico, General Catalyst, and Lakestar reaffirmed their commitment, joined by new backers including Liberty City Ventures, Positive Sum, and BDT & MSD. This latest capital infusion brings Neko Health’s disclosed funding since 2023 to over $1 billion.

Notably, the round also attracted high-profile individual investors such as Meta CEO Mark Zuckerberg and Priscilla Chan, former tennis star Maria Sharapova, musician will.i.am, and football legend Thierry Henry, underscoring the broad appeal and perceived potential of Neko’s vision. David Ofer of O.G. Venture Partners is set to join Neko’s board, pending regulatory approval.

What is Neko Health’s AI Scan?

In practical terms, At its core, Neko Health provides a unique preventive screening service that integrates advanced medical imaging, comprehensive blood tests, proprietary sensor technology, and expert clinician review. The goal is to offer a holistic, non-invasive health assessment that can flag early signs of various conditions, including skin cancer, cardiovascular disease, and diabetes. The company emphasizes a 60-minute, radiation-free experience, designed for convenience and peace of mind.

A Look at the Technology and Process

The Neko Health scan is a sophisticated process involving several key components:

• Full-Body Imaging: Over 2,000 high-resolution images are captured to map the customer’s skin, aiding in the detection of dermatological concerns.
• Advanced Measurements: The scan includes an electrocardiogram (ECG), arterial measurements, and detailed body-composition analysis.
• Proprietary Sensors: Custom-built sensors are used to examine skin conditions, blood abnormalities, and risk factors associated with metabolic syndrome, stroke, and heart attack.
• On-Site Blood Analysis: Blood samples are processed directly at the clinic, allowing for immediate review of results during the same visit. This includes screening for pre-diabetes indicators, cholesterol levels, and blood glucose.

For example, Results are then discussed in a personalized, in-person consultation with a medical professional, who provides insights and recommendations. While many individual measurements are available through conventional healthcare, Neko’s innovation lies in combining them with proprietary imaging, automated data collection, and on-site processing into a single, streamlined appointment.

Neko has also been advancing its technology, recently adding body-composition measurements and clinician reviews of wearable-device data, alongside updated versions of its Derma, Echo, and Spectrum medical devices to capture more health data and automate scanning processes.

Global Footprint and US Rollout

That said, Neko Health currently operates eight clinics across the UK and Sweden, including locations in London, Manchester, Birmingham, and Stockholm. Since launching its service in 2023, the company has completed 100,000 scans, with over 350,000 people registering for a scan or joining waitlists. A remarkable 75% of customers reportedly book and prepay for a follow-up scan, allowing for longitudinal tracking of health metrics.

The upcoming New York clinic marks the first step in its US expansion, with a waitlist already open. While the company has not yet disclosed US pricing, scans in the UK cost approximately £299 (around $400) and 2,750 Swedish Kronor (about $285) in Sweden.

Navigating the US Healthcare Landscape

Interestingly, Operating in the complex US healthcare environment, Neko Health positions its US clinics as “preventive health and wellness providers” rather than full-service medical practices. It’s important for customers to understand that Neko advises them to continue seeing their existing clinicians for diagnoses and treatment, even for conditions identified through a Neko scan.

While two of Neko’s internally developed devices (Derma-2 and Spectrum-2) received FDA clearance in May 2026 for specific uses, these clearances apply to the devices themselves, not the complete Neko Health Scan as an FDA-approved screening service. Furthermore, Neko’s US clinics do not currently participate in health insurance plans, meaning customers are expected to pay directly for the initial assessment.

The Ongoing Discussion on Clinical Evidence

However, As with many innovative health technologies, the question of comprehensive clinical validation is paramount. Publicly available information regarding Neko Health’s full screening service does not yet include a completed, peer-reviewed study validating its overall clinical efficacy or cost-effectiveness compared to established preventive care pathways.

An ongoing trial is evaluating the suitability of its multimodal skin-imaging technology for screening applications, but this does not cover the complete service. Neko’s internal analysis of 1,469 customers who completed a second scan showed reported improvements in blood pressure, cholesterol, and blood sugar.

However, the company acknowledges this was not a scientific study and lacked a control group, meaning it doesn’t definitively establish the scans as the cause of these improvements. Transparency regarding false-positive rates, follow-up procedures, and the extent of AI’s independent diagnostic role versus clinician review also remains a point of discussion for the broader medical community.

Expert Perspective

From an industry angle, the clearest signal around Neko Health AI Scans is how it may influence neko. The story reads less like a one-day spike and more like a marker of broader movement.

The next phase will depend on how quickly teams, regulators, or customers react. In practice, that gives Neko Health AI Scans room to reshape expectations across health over the near term.

For readers focused on practical impact, the best next step is to watch what changes around scan once attention turns into execution.

Frequently Asked Questions

Why does Neko Health AI Scans matter right now?

Neko Health Secures 0M to Bring AI-Powered Preventive Scans to the USFor readers tracking the shift, Neko Health, the innovative health tech company co-founded by Spotify’s Daniel Ek, has announced a significant Series C funding round of 0 million.

What broader change could Neko Health AI Scans signal?

This substantial investment is earmarked for an ambitious expansion into the United States, beginning with a flagship clinic in New York.

What should the market watch next around Neko Health AI Scans?

Neko Health aims to redefine preventive healthcare by offering comprehensive, AI-driven body scans designed to identify potential health risks early.The Funding Powering ExpansionMeanwhile, The Series C round saw strong participation, led by Lightspeed Venture Partners and co-led by O.G.

Conclusion

The headline is important, but the follow-through will shape the real outcome. Meanwhile, Neko Health’s substantial funding and ambitious US expansion signal a growing interest in proactive, technology-driven preventive health. By combining advanced AI, proprietary sensors, and clinician expertise, Neko aims to empower individuals with earlier insights into their health. As the company expands its footprint and continues its research and development, the ongoing dialogue around comprehensive clinical evidence and integration with traditional healthcare pathways will be crucial for its long-term impact on how we approach wellness and disease prevention.

Source: https://www.artificialintelligence-news.com/news/neko-health-700m-ai-body-scans-us/